Carter Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$810K Sell
2,236
-36
-2% -$12.3K 0.42% 49
2026
Q1
$800K Sell
2,272
-55
-2% -$19.6K 0.49% 43
2025
Q4
$762K Buy
2,327
+130
+6% +$41.2K 0.45% 43
2025
Q3
$620K Sell
2,197
-52
-2% -$15.1K 0.37% 48
2025
Q2
$623K Buy
+2,249
New +$637K 0.41% 47

Other funds holding AMGN

Carter Financial Group's AMGN Position: Q2 2026 in Review

Carter Financial Group reduced its Amgen (AMGN) stake by 1.6% in Q2 2026, selling an estimated $12.3K and leaving 2,236 shares worth $810K. The position accounts for 0.42% of the portfolio, ranked #49.

Carter Financial Group first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Carter Financial Group held 2,236 shares of Amgen worth $810K as of Q2 2026.
  • Carter Financial Group sold 36 Amgen shares in Q2 2026, an estimated $12.3K.
  • Amgen made up 0.42% of Carter Financial Group's portfolio in Q2 2026, its #49 holding.
  • Carter Financial Group first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Carter Financial Group's 13F filing for Q2 2026, filed 30 Jul 2026.